________________
FORM
8-K
________________
|
||
CURRENT
REPORT
Pursuant
to Section 13 OR 15(d) of
the
Securities Exchange Act of 1934
|
||
Date
of Report (Date of earliest event reported): May 7,
2009
|
||
Micrus
Endovascular Corporation
(Exact
name of registrant as specified in its charter)
|
||
000-51323
(Commission
File Number)
|
||
Delaware
(State
or other jurisdiction of incorporation)
|
23-2853441
(IRS
Employer
Identification
No.)
|
|
821
Fox Lane
San
Jose, CA 95131
(Address
of principal executive offices with zip code)
|
||
(408)
433-1400
(Registrant’s
telephone number, including area code)
Not
Applicable
(Former name or former
address, if changed since last report)
|
Results
of Operations and Financial
Condition.
|
Financial
Statements and Exhibits.
|
(d)
|
Exhibits.
|
Exhibit
|
Description
|
|
99.1
|
Press
Release dated May 7, 2009.
|
MICRUS
ENDOVASCULAR CORPORATION
(Registrant)
|
|
Date:
May 7, 2009
|
By: /s/
Gordon T.
Sangster
Gordon
T. Sangster
Chief
Financial Officer
|
Exhibit
|
Description
|
|
99.1
|
Press
Release dated May 7, 2009
|